Last update 01 Nov 2024
PDGFRα x DDR1 x VEGFR2 x VEGFR3 x PDGFRβ x DDR2
Last update 01 Nov 2024
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
一项评价ICP-033在实体瘤患者中的安全性、耐受性、药代动力学的I 期临床试验
[Translation] A Phase I clinical trial evaluating the safety, tolerability, and pharmacokinetics of ICP-033 in patients with solid tumors
A Phase I Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of ICP-033 in Patients With Solid Tumors
100 Clinical Results associated with PDGFRα x DDR1 x VEGFR2 x VEGFR3 x PDGFRβ x DDR2
Login to view more data
100 Translational Medicine associated with PDGFRα x DDR1 x VEGFR2 x VEGFR3 x PDGFRβ x DDR2
Login to view more data
Login to view more data
Analysis
Perform a panoramic analysis of this field.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free